Andrew Penn, MS, NP, PMHNP-BC is a University of California San Francisco trained psychiatric nurse practitioner, nationally-recognized speaker on psychedelic assisted therapy and cannabinoids in psychiatry and a co-founder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses). Andrew completed extensive training in psychedelic assisted therapy and has worked as a study therapist on a phase 3 MDMA-assisted therapy protocol for PTSD and is Co-investigator on a study of psilocybin assisted therapy for major depression. He speaks to us today about psychedelic-assisted therapies. Episode Highlights: - What Post-Traumatic Stress Disorder (PTSD) is - The parts of the brain affected by traumatic experiences - "Window of Tolerance" after trauma - The history of MDMA and psychedelics - MDMA-assisted therapy for PTSD - How psychedelics can be seen as a "quick fix" - Why psychedelic medicine is considered contextual - Psilocybin assisted therapy for major depression - The default-mode network vs the task-positive network - Barriers in this field of psychedelic research For more information about Andrew Penn, please visit https://www.andrewpennnp.com/ Organization of Psychedelic and Entheogenic Nurses https://www.openurses.org/ Laboratory https://psychedelics.ucsf.edu/